Medication info

Sitagliptin 100 mg (Sitagliptin Phosphate Hydrate)

Prescription medicationTabletExpired
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
(Yoo) Hanpung Pharmaceutical Co., Ltd.
Appearance
Beige, round, double-sided convex film-coated tablet
Packaging
30 tablets/bottle, 90 tablets/bottle
Approval status
Expired

MFDS item code 202008323 · Approved 2020.11.30

This product's status changed to Expired on 2025.11.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who uses it
Adults
Adult dosage
This drug is administered at 100 mg once daily, either as monotherapy or in combination therapy. The maximum daily dose is 100 mg. This drug may be taken with or without food. When administered in combination with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dose adjustment according to renal function is required, evaluation of renal function is recommended before starting this drug and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This drug may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
(Yoo) Hanpung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

  • Type 2 diabetes
  • blood sugar control disorder
View approved original text

This drug is used as an adjunct to improve blood sugar control in patients with Type 2 diabetes in combination with dietary therapy and physical activity. Patients without prior experience in diabetes treatment may take this drug alone. If blood sugar control is difficult, it can be taken with metformin and is also effective when combined with other diabetes medications such as sulfonylureas, thiazolidinediones, and insulin. If various combination therapies are insufficient for blood sugar control, this drug can be added to aid in blood sugar improvement. This drug is utilized as monotherapy or in combination therapy tailored to the individual patient's treatment situation, effectively improving blood sugar control.

Dosage and Administration

Adult dosage

This drug is administered at 100 mg once daily, either as monotherapy or in combination therapy. The maximum daily dose is 100 mg. This drug may be taken with or without food. When administered in combination with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dose adjustment according to renal function is required, evaluation of renal function is recommended before starting this drug and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This drug may be administered regardless of the timing of dialysis.

Precautions

This drug may rarely cause severe allergic reactions; if symptoms such as rash, itching, or difficulty breathing occur, discontinue use immediately and consult a physician. While taking this drug, symptoms of pancreatitis, which indicates inflammation of the pancreas, may appear; inform medical personnel immediately if you experience abdominal pain, vomiting, or severe abdominal discomfort. Do not take this drug if you are a patient with Type 1 diabetes or diabetic ketoacidosis. Patients who have had an allergic reaction to this drug or its components should not take it. Patients with impaired renal function should adjust the dose of this drug, and regular kidney function tests are important. During treatment, you may experience cold-like symptoms, headache, indigestion, diarrhea, etc.; if symptoms persist or worsen, consult a physician. If taken together with other blood-glucose-lowering agents such as insulin or sulfonylureas, hypoglycemia may occur, so blood sugar levels should be checked frequently, and the dose of those medications should be adjusted if necessary. This drug is not recommended for pregnant or breastfeeding women, and safety and efficacy in children under 18 years have not been established. Elderly patients may have decreased renal function, so it is advisable to check kidney function before and after taking the drug. In case of overdose, visit a healthcare institution immediately for appropriate action; some of the drug may be removed via hemodialysis. If you develop blisters or severe itching on the skin while taking this drug, inform a physician immediately, and if necessary, the medication may be discontinued. There are few interactions with other medications, but it is safe to consult with a physician or pharmacist when taking specific medications.

Side effects

Severe hypersensitivity reaction, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative skin disease, acute pancreatitis, hypoglycemia, upper respiratory infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, peripheral edema, constipation, vomiting, arthralgia accompanied by severe and disability, bullous pemphigoid-like dermatitis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent air and moisture. Moreover, it is advisable to store it at room temperature between 1 degree and 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Beige, round, double-sided convex film-coated tablet

Package unit

30 tablets/bottle, 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.